KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Amortization of Deferred Charges: 2009-2016

Historic Amortization of Deferred Charges for Charles River Laboratories International (CRL) over the last 8 years, with Dec 2016 value amounting to $506,000.

  • Charles River Laboratories International's Amortization of Deferred Charges rose 23.41% to $506,000 in Q4 2016 from the same period last year, while for Dec 2016 it was $2.8 million, marking a year-over-year increase of 18.95%. This contributed to the annual value of $2.8 million for FY2016, which is 18.95% up from last year.
  • Per Charles River Laboratories International's latest filing, its Amortization of Deferred Charges stood at $506,000 for Q4 2016, which was up 1,388.24% from $34,000 recorded in Q3 2016.
  • Charles River Laboratories International's 5-year Amortization of Deferred Charges high stood at $4.6 million for Q1 2013, and its period low was $34,000 during Q3 2016.
  • Its 3-year average for Amortization of Deferred Charges is $578,000, with a median of $428,500 in 2014.
  • In the last 5 years, Charles River Laboratories International's Amortization of Deferred Charges skyrocketed by 165.36% in 2015 and then plummeted by 91.46% in 2016.
  • Over the past 5 years, Charles River Laboratories International's Amortization of Deferred Charges (Quarterly) stood at $4.5 million in 2012, then tumbled by 90.26% to $437,000 in 2013, then declined by 2.29% to $427,000 in 2014, then decreased by 3.98% to $410,000 in 2015, then climbed by 23.41% to $506,000 in 2016.
  • Its Amortization of Deferred Charges stands at $506,000 for Q4 2016, versus $34,000 for Q3 2016 and $1.9 million for Q2 2016.